Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 00:37 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Intra Articular Injection of Botulinum Toxin Versus Corticoids in Gonarthrosis
NCT03726788 · Lille Catholic University · PHASE2 · withdrawn · last registry update 2025-09-10 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “discontinuation of the study” | – | Registry record, Lille Catholic University |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against SNAP25 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2026-08-31Results posted on the registry: Eirion Therapeutics Inc., AI-09 + Vehicle (NCT05565950)
- 2026-08-25Phase 3 first posted: Daewoong Pharmaceutical Co. LTD., DWP450 20 U + 0.9% Saline Solution 0.5 mL (NCT07783763)
- 2026-08-12Phase 3 first posted: Khon Kaen University, Botulinum toxin A via microneedle (NCT07759557)
- 2026-07-30Results posted on the registry: Isabel Moreno Hay, onabotulinum toxin A (NCT03848143)
- 2026-07-27Results posted on the registry: University of Florida, Zinc gluconate supplement + Botulinum toxin type A (NCT05892770)
- 2026-07-09Results posted on the registry: Ipsen, AboBoNT-A + OnaBoNT-A (NCT04936542)
- 2026-06-29Results posted on the registry: Beth Israel Deaconess Medical Center, OnabotulinumtoxinA 145 UNT [Botox] (NCT05605756)
- 2026-06-29Also stopped (terminated): Beth Israel Deaconess Medical Center, OnabotulinumtoxinA 145 UNT [Botox] (NCT05605756)
- 2026-06-24Also stopped (terminated): University Hospital, Bordeaux, Dysport 500 Unit Powder for Injection (NCT03496649)
- 2026-06-24Also stopped (withdrawn): houyajing, Ultrasound-Guided Botulinum Toxin Type A (BoNT-A) Salivary Gland Injection + Control (Normal saline) (NCT07070817)
- 2026-06-16Results posted on the registry: AbbVie, Atogepant (NCT05216263)
- 2026-06-09Also stopped (withdrawn): University Hospital, Limoges, BOTOX (NCT01325090)
- 2026-06-02Phase 3 first posted: INIBIO Co., Ltd., Botulinum Toxin Type A Injection [INI101] + Botulinum Toxin Type A Injection [Botox] (NCT07622004)
- 2026-06-01Also stopped (terminated): University Hospital, Toulouse, a drug against SNAP25 (NCT03783572)
- 2026-05-27Results posted on the registry: Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC, Phase 2; Low Dose MYOBLOC (10,000 Units) + Phase 2; High Dose MYOBLOC (20,000 Units) (NCT04815967)
- 2026-05-27Also stopped (terminated): Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC, Phase 2; Low Dose MYOBLOC (10,000 Units) + Phase 2; High Dose MYOBLOC (20,000 Units) (NCT04815967)
- 2026-05-22Results posted on the registry: Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC, Phase 2; Low Dose MYOBLOC (15,000 Units) + Phase 2; High Dose MYOBLOC (20,000 Units) (NCT04099667)
- 2026-05-22Also stopped (terminated): Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC, Phase 2; Low Dose MYOBLOC (15,000 Units) + Phase 2; High Dose MYOBLOC (20,000 Units) (NCT04099667)
- 2026-05-20Results posted on the registry: Recep Tayyip Erdogan University, PrabotulinumtoxinA + Abobotulinumtoxina (NCT07452510)
- 2026-04-28Results posted on the registry: Merz Pharmaceuticals GmbH, NT 201 + Placebo (NCT04766723)
- 2026-03-27Results posted on the registry: University of California, San Francisco, DaxibotulinumtoxinA (NCT05158166)
- 2026-03-18Phase 3 first posted: Chongqing Claruvis Pharmaceutical Co., Ltd., Recombinant botulinum toxin type A for injection (YY001) (NCT07478822)
- 2026-03-13Phase 3 first posted: Jaeb Center for Health Research, Botulinum toxin A (NCT07470164)
- 2026-02-12Also stopped (withdrawn): University of Alabama at Birmingham, Vibegron 75mg + Placebo (NCT06438861)
- 2026-01-30Also stopped (terminated): Hospices Civils de Lyon, Botox® injection + Scopoderm® patches arm (NCT03616067)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision